search
Back to results

Sprint Interval Training in Patients With Chronic Obstructive Lung Disease

Primary Purpose

Pulmonary Disease, Chronic Obstructive

Status
Completed
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
sprint interval training
Sponsored by
Norwegian University of Science and Technology
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pulmonary Disease, Chronic Obstructive focused on measuring Exercise therapy, High-Intensity Interval Training

Eligibility Criteria

50 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria (patients):

  • stable CPOD stage 3 and 4 according to GOLD guidelines (www.goldcopd.org)
  • post bronchodilator FEV < 50%

Exclusion Criteria:

  • having participated in a pulmonary rehabilitation program during the last 3 months.

Sites / Locations

  • St Olavs University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

chronic obstructive lung disease

healthy control

Arm Description

Outcomes

Primary Outcome Measures

exercise cycle time to exhaustion

Secondary Outcome Measures

Full Information

First Posted
November 7, 2018
Last Updated
January 9, 2020
Sponsor
Norwegian University of Science and Technology
search

1. Study Identification

Unique Protocol Identification Number
NCT03735615
Brief Title
Sprint Interval Training in Patients With Chronic Obstructive Lung Disease
Official Title
Sprint Interval Training in Patients With Chronic Obstructive Lung Disease
Study Type
Interventional

2. Study Status

Record Verification Date
January 2020
Overall Recruitment Status
Completed
Study Start Date
November 15, 2018 (Actual)
Primary Completion Date
March 10, 2019 (Actual)
Study Completion Date
March 10, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Norwegian University of Science and Technology

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Exercise therapy is a cornerstone in the management of patients with Chronic Obstructive Pulmonary disease (COPD), and supervised walking exercise three times a week over 12 weeks improves walking ability and quality of life. Despite this, very few patients exercise on a regular basis. The underuse of exercise in COPD patients can partly be explained by discomfort during exercise because it evokes dyspnea, and thereby explain lack of participation in exercise. If the goal is to offer the best medical therapy to these patients, new and effective exercise training methods must be explored and defined since exercise training is an important part of pulmonary rehabilitation. Intention is to study a new training method called sprint interval training (SIT), which consists of high intensity bouts with very short duration. The idea behind SIT is to avoid the dyspnea associated with traditional endurance training, thus maximizing exercise power without excessive discomfort. The investigators will study training adaptations in patients with COPD and compare the results with age-matched controls. It is expected that both COPD-patients and healthy elderly will improve exercise cycle time until exhaustion after SIT training, and also that the improvement will be larger in the healthy group due to higher absolute training intensity.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pulmonary Disease, Chronic Obstructive
Keywords
Exercise therapy, High-Intensity Interval Training

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
10 patients with stable chronic obstructive lung disease (COPD) stage 3 and 4 according to GOLD guidelines (www.goldcopd.org), recruited from outpatient ward of the Lung Department at St Olav University Hospital. Control group of 10 age-matched but otherwise healthy subjects
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
20 (Actual)

8. Arms, Groups, and Interventions

Arm Title
chronic obstructive lung disease
Arm Type
Experimental
Arm Title
healthy control
Arm Type
Experimental
Intervention Type
Behavioral
Intervention Name(s)
sprint interval training
Intervention Description
Each training session will be performed 3 times per week for 3 weeks. Each session consists of 3-5x20 sec all-out cycling efforts against a load corresponding to 0.05-0.07 kg/kg body mass, separated by 3-5 min of low intensity cycling (20-50 W), on a lode bicycle ergometer (Excalibur Sport V2.0, Groningen, the Netherlands). All training sessions includes a 5 min warm-up and 3 min cool-down.
Primary Outcome Measure Information:
Title
exercise cycle time to exhaustion
Time Frame
3 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria (patients): stable CPOD stage 3 and 4 according to GOLD guidelines (www.goldcopd.org) post bronchodilator FEV < 50% Exclusion Criteria: having participated in a pulmonary rehabilitation program during the last 3 months.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Øystein Risa, phd
Organizational Affiliation
Norwegian University of Science and Technology
Official's Role
Study Director
Facility Information:
Facility Name
St Olavs University Hospital
City
Trondheim
Country
Norway

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Sprint Interval Training in Patients With Chronic Obstructive Lung Disease

We'll reach out to this number within 24 hrs